Anzeige
Mehr »
Samstag, 10.01.2026 - Börsentäglich über 12.000 News
Fundamental stark, Kurs zu niedrig - Chance beim Krebs-Impfstoff-Pionier!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A4091K | ISIN: US6294442099 | Ticker-Symbol: B1Q
Tradegate
09.01.26 | 21:16
1,920 Euro
-4,00 % -0,080
Branche
Pharma
Aktienmarkt
Sonstige
1-Jahres-Chart
NRX PHARMACEUTICALS INC Chart 1 Jahr
5-Tage-Chart
NRX PHARMACEUTICALS INC 5-Tage-Chart
RealtimeGeldBriefZeit
1,8701,95009.01.
ACCESS Newswire
495 Leser
Artikel bewerten:
(2)

New to The Street Show #682 Premieres on Bloomberg Tonight Featuring Industry Leaders: DataVault, PetVivo, Health In Tech, FLOKI, and NRx Pharma Backed by National TV Commercials and Outdoor Campaigns Sponsored by MUSQ, ArriveAI, and Sustainable Green Tea

Backed by National TV Commercials and Outdoor Campaigns Sponsored by MUSQ, ArriveAI, and Sustainable Green Team

NEW YORK CITY, NEW YORK / ACCESS Newswire / August 1, 2025 / New to The Street, the nation's leading financial media platform, proudly announces the broadcast of Show #682, airing this evening at 9:30 PM PST on Bloomberg Television as sponsored programming. This episode showcases transformative companies driving innovation across artificial intelligence, veterinary health, blockchain, healthcare SaaS, and pharmaceutical sectors.

Featured Interviews on Episode #682 Include:

- DataVault Holdings Inc. (NASDAQ:DVLT)
CEO Nathaniel Bradley highlights the company's enterprise expansion, announcing the debut of AI agents powered by IBM watsonx.ai. This breakthrough enables corporate clients to securely monetize data using compliant, intelligent automation. DataVault AI's growing partnerships with IBM and other tech leaders demonstrate its position at the forefront of AI + Web3 convergence-empowering businesses to unlock value from untapped data assets.

- PetVivo Holdings Inc. (NASDAQ:PETV)
PetVivo continues its rapid commercial rollout of SPRYNG with OsteoCushion Technology, now adopted by over 1,200 veterinary clinics across the United States. The company is also making strategic inroads into the equine space through its new partnership with Commonwealth Thoroughbreds-aimed at advancing equine joint wellness and performance across top-tier racing circuits. This milestone reflects PetVivo's growing leadership in the $3B+ animal therapeutics market, with SPRYNG providing a drug-free, minimally invasive solution to joint pain in companion and performance animals.

- Health In Tech
Health In Tech presents its disruptive approach to benefits administration via an end-to-end SaaS platform designed for brokers, employers, and TPAs. The solution's intuitive interface and real-time quoting tools deliver speed, efficiency, and scalability for today's healthcare benefits landscape.

- FLOKI
Leaders from FLOKI discuss their growing DeFi ecosystem and global presence, with recent expansions into financial education tools, community governance, and real-world payment infrastructure.

- NRx Pharmaceuticals (NASDAQ:NRXP)
CEO Dr. Jonathan Javitt offers an update on the company's late-stage pharmaceutical developments for bipolar depression, PTSD, and other CNS disorders, while continuing to advance FDA engagement for its proprietary pipeline.

National TV Commercial Support:

High-frequency national commercials and campaigns are airing in conjunction with the show for:

  • NRx Pharmaceuticals

  • ArriveAI

  • Sustainable Green Team (SGTM)

  • MUSQ - The Music ETF

Campaigns are focused on national television and the #1 NYC DMA, targeting high-investor-density zones and financial news audiences.

Cross-Platform Distribution & Outdoor Exposure:

All interviews are distributed via New to The Street's YouTube channel (3.1M+ subscribers) and promoted across LinkedIn, Twitter/X, Instagram, and Facebook. Clients also receive billboard exposure across Times Square, Wall Street, and NYC Financial District bus shelters, with additional reach through syndicated earned media on ABC, NBC, and CBS local affiliates.

July Performance: A Record Month for Client Renewals

July saw 9 clients signing new or renewed media agreements across broadcast, digital, and outdoor campaigns - driven by demand for New to The Street's unmatched national visibility and investor engagement platform. These results position the network as the leading multi-channel awareness engine for small- to mid-cap growth companies.

About New to The Street:
New to The Street is a premier television business brand broadcasting sponsored programming on Fox Business and Bloomberg Television. With a loyal YouTube following of over 3.1 million subscribers, iconic outdoor billboard access, and strong earned media distribution, New to The Street delivers a 360-degree media solution for public and private companies seeking scale, credibility, and conversion.

Media Contact:
Monica Brennan
Monica@NewToTheStreet.com
www.NewToTheStreet.com

SOURCE: New to The Street



View the original press release on ACCESS Newswire:
https://www.accessnewswire.com/newsroom/en/publishing-and-media/new-to-the-street-show-%23682-premieres-on-bloomberg-tonight-featuring-industry-1055586

© 2025 ACCESS Newswire
Renditeturbo 2026 - 5 Aktien mit Potenzial
2025 neigt sich dem Ende zu, ohne klassische Jahresendrallye, aber mit einem DAX, der viele Kritiker Lügen gestraft hat. Über 21 Prozent Kursplus seit Jahresbeginn, stärker als der US-Markt. Wer hätte das noch vor Monaten erwartet?

Genau solche Entwicklungen machen den Reiz der Börse aus. Denn auch 2026 dürfte wieder alles anders kommen als gedacht. Während viele Analysten weiter steigende Kurse erwarten, rückt eine zentrale Frage in den Fokus: Wo entstehen im kommenden Jahr echte Überraschungen, und wie kann man davon profitieren?

Unser aktueller Spezialreport beleuchtet fünf Entwicklungen, mit denen kaum jemand rechnet, die aber enormes Renditepotenzial bergen. Vom Comeback der Ölwerte über unterschätzte Plattform-Aktien bis hin zur möglichen Wachablösung im KI-Sektor: Wer 2026 überdurchschnittlich abschneiden will, muss antizyklisch denken und frühzeitig Position beziehen.

Im kostenlosen Report stellen wir 5 Aktien vor, die 2026 im Zentrum solcher Wendepunkte stehen könnten. Solide bewertet, gut positioniert und mit überraschend starkem Momentum.

Jetzt kostenlos herunterladen! Bevor andere erkennen, wo die Chancen wirklich liegen!

Dieses exklusive PDF ist nur für kurze Zeit verfügbar.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.